Emerging Trends to Drive Cellular Therapy Tracking Market Growth at 12.9% CAGR Through 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cellular Therapy Tracking Market Size Growth Forecast: What to Expect by 2025?
The market size for cellular therapy tracking has experienced swift expansion in recent times. The projected growth is from $2.56 billion in 2024 to $2.90 billion in 2025, which corresponds to a compound annual growth rate (CAGR) of 13.3%. This increase in the past period is due to factors such as heightened clinical trials in regenerative medicine, a surge in personalized medicine interest, the broadening of academic and industry partnerships, an enhanced understanding of the effectiveness and safety of cell therapy, along with increased investment and venture funds into cell and gene therapy firms.

How Will the Cellular Therapy Tracking Market Size Evolve and Grow by 2029?
Predictions indicate a quick expansion for the cellular therapy tracking market in the upcoming years, with its value anticipated to reach $4.71 billion in 2029, showing a compound annual growth rate (CAGR) of 12.9%. The projected growth during this forecast period is linked to the increasing acceptance of precision and personalized medicine, a wider range of cell and gene therapies, a surge in clinical trials and commercial approvals, rising frequency of chronic and unusual diseases, and the growth of cell therapy production facilities. The period is also expected to see several key trends such as the combination of cell therapy tracking with digital health platforms, the incorporation of bioinformatics in cellular research, breakthrough in cellular therapy study, comprehensive regulatory-compliance tools, and the integration of artificial intelligence and machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cellular-therapy-tracking-global-market-report

What Drivers Are Propelling the Growth of Cellular Therapy Tracking Market Forward?
The anticipated growth in the cellular therapy tracking market is projected to be propelled by the growing embracement of personalized medicine. Personalized medicine constitutes a medical approach that molds prevention and treatment methods according to a person's individual genetic composition, lifestyle, and environment. The surge in the adoption of personalized medicine is chiefly attributed to advancements in genomics which allow for exact determination of genetic variations and personalized treatments for individuals. Cellular therapy tracking champions personalized medicine by ensuring precise supervision and administration of cells that are unique to each patient throughout the therapy program. This improves safety and effectiveness of treatments by offering comprehensive tracking, adherence to regulations, and a streamlined work process for health practitioners. For example, as reported by the Personalized Medicine Coalition (PMC), a nonprofit organization in the U.S, in February 2024, the U.S. Food and Drug Administration (FDA) issued approval for 26 new personalized medicines in 2023, a considerable rise from the 12 approved in 2022. Consequently, it is the escalating adoption of personalized medicine that is propelling the growth of the cellular therapy tracking market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28162&type=smp

Which Emerging Trends Are Transforming the Cellular Therapy Tracking Market in 2025?
Leading companies engaged in the field of cellular therapy tracking market are focusing their efforts on the creation of scalable platforms, such as Chain of Identity (COI) management platforms. These platforms help ensure cell traceability, regulatory adherence, and patient safety. COI management platforms are essentially digital systems that monitor and authenticate the identity of cells specific to individual patients throughout the entire process of cellular therapy, thereby guaranteeing traceability and the safety of patients. TrakCel Limited, a software company based in the UK, introduced OCELLOS Core to its OCELLOS suite in May 2023. It was developed as a COI management platform for early-stage autologous and personalized cell and gene therapy (CGT) clinical trials. OCELLOS Core delivers automated COI tracking, ensuring the accuracy of patient records from the point of initial enrollment. The system, which is pre-configured and validated, can be launched within the timeframe of 2-3 weeks, providing cost-effective scalability as therapies move from trials to commercial release. It also monitors the chain of custody events with comprehensive audit trails, enhancing regulatory compliance and collaboration.

What Are the Key Segments in the Cellular Therapy Tracking Market?
The cellular therapy tracking market covered in this report is segmented as

1) By Product Type: Software, Services
2) By Application: Cancer, Cardiovascular Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications
3) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End Users

Subsegments:
1) By Software: Patient Registry Software, Clinical Trial Management Software, Electronic Data Capture (EDC) Systems, Laboratory Information Management Systems (LIMS), Cell Therapy Supply Chain Management Software, Compliance And Reporting Software, Data Analytics And Visualization Tools
2) By Services: Implementation And Integration Services, Training And Education Services, Consulting Services, Managed Services, Technical Support And Maintenance, Data Security And Compliance Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28162&type=smp

Who Are the Key Players Shaping the Cellular Therapy Tracking Market's Competitive Landscape?
Major companies operating in the cellular therapy tracking market are Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Gilead Sciences Inc., Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Lonza Group Ltd., Nikon Corporation, Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Vericel Corporation, Adaptimmune Therapeutics plc, Medipost Co. Ltd., and TrakCel.

What Geographic Markets Are Powering Growth in the Cellular Therapy Tracking Market?
North America was the largest region in the cellular therapy tracking market in 2024. The regions covered in cellular therapy tracking report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28162

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.